Global Generic Oncology Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 118 pages | ID: G48F51F36D3GEN
GlobalInfoResearch

Abstracts

SCOPE OF THE REPORT:

The global Generic Oncology Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Generic Oncology Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Generic Oncology Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Generic Oncology Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Pfizer
• GlaxoSmithKline
• Novartis
• Merck
• Celgene
• Teva Pharmaceutical
• Mylan
• Aurobindo Pharma
• Hikma Pharmaceuticals
• Natco Pharma

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Large Molecule Drugs
• Small Molecule Drugs

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Contents

1 GENERIC ONCOLOGY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Generic Oncology Drugs
1.2 Classification of Generic Oncology Drugs by Types
  1.2.1 Global Generic Oncology Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Generic Oncology Drugs Revenue Market Share by Types in 2017
  1.2.3 Large Molecule Drugs
  1.2.4 Small Molecule Drugs
1.3 Global Generic Oncology Drugs Market by Application
  1.3.1 Global Generic Oncology Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Generic Oncology Drugs Market by Regions
  1.4.1 Global Generic Oncology Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Generic Oncology Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Generic Oncology Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Generic Oncology Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Generic Oncology Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Generic Oncology Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Generic Oncology Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Generic Oncology Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
  2.2.1 Business Overview
  2.2.2 Generic Oncology Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 GlaxoSmithKline Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
  2.3.1 Business Overview
  2.3.2 Generic Oncology Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Novartis Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
  2.4.1 Business Overview
  2.4.2 Generic Oncology Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Merck Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celgene
  2.5.1 Business Overview
  2.5.2 Generic Oncology Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Celgene Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical
  2.6.1 Business Overview
  2.6.2 Generic Oncology Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Teva Pharmaceutical Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mylan
  2.7.1 Business Overview
  2.7.2 Generic Oncology Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Mylan Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Aurobindo Pharma
  2.8.1 Business Overview
  2.8.2 Generic Oncology Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Aurobindo Pharma Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hikma Pharmaceuticals
  2.9.1 Business Overview
  2.9.2 Generic Oncology Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Hikma Pharmaceuticals Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Natco Pharma
  2.10.1 Business Overview
  2.10.2 Generic Oncology Drugs Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Natco Pharma Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL GENERIC ONCOLOGY DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Generic Oncology Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Generic Oncology Drugs Players Market Share
  3.2.2 Top 10 Generic Oncology Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL GENERIC ONCOLOGY DRUGS MARKET SIZE BY REGIONS

4.1 Global Generic Oncology Drugs Revenue and Market Share by Regions
4.2 North America Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Generic Oncology Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA GENERIC ONCOLOGY DRUGS REVENUE BY COUNTRIES

5.1 North America Generic Oncology Drugs Revenue by Countries (2013-2018)
5.2 USA Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Generic Oncology Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE GENERIC ONCOLOGY DRUGS REVENUE BY COUNTRIES

6.1 Europe Generic Oncology Drugs Revenue by Countries (2013-2018)
6.2 Germany Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
6.4 France Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Generic Oncology Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC GENERIC ONCOLOGY DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Generic Oncology Drugs Revenue by Countries (2013-2018)
7.2 China Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
7.5 India Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA GENERIC ONCOLOGY DRUGS REVENUE BY COUNTRIES

8.1 South America Generic Oncology Drugs Revenue by Countries (2013-2018)
8.2 Brazil Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE GENERIC ONCOLOGY DRUGS BY COUNTRIES

9.1 Middle East and Africa Generic Oncology Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Generic Oncology Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL GENERIC ONCOLOGY DRUGS MARKET SEGMENT BY TYPE

10.1 Global Generic Oncology Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Generic Oncology Drugs Market Forecast by Type (2018-2023)
10.3 Large Molecule Drugs Revenue Growth Rate (2013-2023)
10.4 Small Molecule Drugs Revenue Growth Rate (2013-2023)

11 GLOBAL GENERIC ONCOLOGY DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Generic Oncology Drugs Revenue Market Share by Application (2013-2018)
11.2 Generic Oncology Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL GENERIC ONCOLOGY DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Generic Oncology Drugs Market Size Forecast (2018-2023)
12.2 Global Generic Oncology Drugs Market Forecast by Regions (2018-2023)
12.3 North America Generic Oncology Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Generic Oncology Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Generic Oncology Drugs Revenue Market Forecast (2018-2023)
12.6 South America Generic Oncology Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Generic Oncology Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Generic Oncology Drugs Picture
Table Product Specifications of Generic Oncology Drugs
Table Global Generic Oncology Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Generic Oncology Drugs Revenue Market Share by Types in 2017
Figure Large Molecule Drugs Picture
Figure Small Molecule Drugs Picture
Table Global Generic Oncology Drugs Revenue (Million USD) by Application (2013-2023)
Figure Generic Oncology Drugs Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Generic Oncology Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Generic Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Generic Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Generic Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Generic Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Generic Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Generic Oncology Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Generic Oncology Drugs Type and Applications
Table Pfizer Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Generic Oncology Drugs Type and Applications
Table GlaxoSmithKline Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Generic Oncology Drugs Type and Applications
Table Novartis Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Generic Oncology Drugs Type and Applications
Table Merck Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Generic Oncology Drugs Type and Applications
Table Celgene Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Generic Oncology Drugs Type and Applications
Table Teva Pharmaceutical Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Generic Oncology Drugs Type and Applications
Table Mylan Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Generic Oncology Drugs Type and Applications
Table Aurobindo Pharma Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals Generic Oncology Drugs Type and Applications
Table Hikma Pharmaceuticals Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Generic Oncology Drugs Type and Applications
Table Natco Pharma Generic Oncology Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Generic Oncology Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Generic Oncology Drugs Revenue Share by Players (2013-2018)
Figure Global Generic Oncology Drugs Revenue Share by Players in 2016
Figure Global Generic Oncology Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Generic Oncology Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Generic Oncology Drugs Revenue Market Share in 2017
Figure Global Generic Oncology Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Generic Oncology Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Generic Oncology Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Generic Oncology Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Generic Oncology Drugs Revenue Market Share by Regions in 2017
Figure North America Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure South America Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Table North America Generic Oncology Drugs Revenue by Countries (2013-2018)
Table North America Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Generic Oncology Drugs Revenue Market Share by Countries in 2017
Figure USA Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Table Europe Generic Oncology Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Generic Oncology Drugs Revenue Market Share by Countries in 2017
Figure Germany Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure UK Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure France Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Generic Oncology Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Generic Oncology Drugs Revenue Market Share by Countries in 2017
Figure China Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure India Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Table South America Generic Oncology Drugs Revenue by Countries (2013-2018)
Table South America Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Generic Oncology Drugs Revenue Market Share by Countries in 2017
Figure Brazil Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Generic Oncology Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Generic Oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Generic Oncology Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Generic Oncology Drugs Revenue and Growth Rate (2013-2018)
Table Global Generic Oncology Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Generic Oncology Drugs Revenue Share by Type (2013-2018)
Figure Global Generic Oncology Drugs Revenue Share by Type (2013-2018)
Figure Global Generic Oncology Drugs Revenue Share by Type in 2017
Table Global Generic Oncology Drugs Revenue Forecast by Type (2018-2023)
Figure Global Generic Oncology Drugs Market Share Forecast by Type (2018-2023)
Figure Global Large Molecule Drugs Revenue Growth Rate (2013-2018)
Figure Global Small Molecule Drugs Revenue Growth Rate (2013-2018)
Table Global Generic Oncology Drugs Revenue by Application (2013-2018)
Table Global Generic Oncology Drugs Revenue Share by Application (2013-2018)
Figure Global Generic Oncology Drugs Revenue Share by Application (2013-2018)
Figure Global Generic Oncology Drugs Revenue Share by Application in 2017
Table Global Generic Oncology Drugs Revenue Forecast by Application (2018-2023)
Figure Global Generic Oncology Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Generic Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Generic Oncology Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Generic Oncology Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Generic Oncology Drugs Revenue Market Forecast (2018-2023)
Figure Europe Generic Oncology Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Generic Oncology Drugs Revenue Market Forecast (2018-2023)
Figure South America Generic Oncology Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Generic Oncology Drugs Revenue Market Forecast (2018-2023)